<DOC>
	<DOCNO>NCT02440633</DOCNO>
	<brief_summary>To obtain absorption , metabolism excretion data parent drug metabolite .</brief_summary>
	<brief_title>A Phase 1 , Open -Label Study Assess Absorption , Metabolism Excretion 14C-OPS-2071 Following Single Oral Dose Healthy Male Japanese Subjects</brief_title>
	<detailed_description />
	<mesh_term>Enteritis</mesh_term>
	<criteria>Healthy male Body mass index ( BMI ) 18.5 25.0 kg/m2 , inclusive Subjects give write informed consent participate study abide study restriction Subjects significant history alcoholism drug/chemical abuse , determine Investigator . Subjects smoke , use nicotine within 3 month prior screening.. Subjects significant history drug allergy , determine Investigator . Subjects clinically significant abnormal physical examination find . Subjects clinically significant medical history , determine Investigator . Subjects expose radiation result occupation . Subjects X ray CT scan , participate trial involve radiolabelled investigational product expose radiolabelled substance within 12 month prior dose administration .</criteria>
	<gender>Male</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>